Leukemia Clinical Trials in Detroit

Showing 1481-1500 of 1,678 trials

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

NCT00441337

To evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, clear cell renal cell cancer or hormone refractory prostate cancer

Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more

Bristol-Myers Squibb39 participantsStarted Aug 2006

Baltimore, Maryland, United States • Detroit, Michigan, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

NCT00123487

This is a phase III study of BMS-354825 in subjects with chronic myelogenous leukemia in accelerated phase, or in myeloid or lymphoid blast phase or with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia who are resistant or intolerant to imatinib mesylate (Gleevec).

Myeloid Leukemia, Chronic, Accelerated PhaseLeukemia, Lymphoblastic, Acute, Philadelphia-Positive

Bristol-Myers Squibb638 participantsStarted Jun 2005

Birmingham, Alabama, United States • Loma Linda, California, United States • Los Angeles, California, United States +116 more locations

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Leukemia Trials in Other Cities

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)

A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Other Conditions in Detroit